TLR3 and schizophrenia: MIA using polyriboinosinic-polyribocytidilic acid [poly(I:C)], a Toll-like receptor 3 agonist, has been widely used as an animal model for schizophrenia since adult offspring after prenatal poly(I:C) exposure show behavioral abnormalities relevant to schizophrenia [12–17].